02661 輕鬆健康
QINGSONG HEALTH
QINGSONG HEALTH
| Register Close | 2025/12/18 IPO Closing in 3 Days |
| Listing Date | 2025/12/23 |
|
|
|
|
|
|
|
|
|
|
IPO Detail
COMPANY PROFILE
QingSong Health Corporation provides healthcare-related and insurance-related solutions in China. The Group ranked 10th in China’s digital integrated healthcare and health insurance services market in terms of revenue in 2024 and seventh in China’s digital healthcare services market in terms of revenue in 2024 according to the report.
--
The Group offers corporate and individual customers, various healthcare-related services, ranging from digital marketing through healthcare-related educational articles and videos, digital medical research assistance, integrated health service packages with various self-operated and outsourced services, and promotion and consultancy to support early disease screening.
--
The Group also provides users with convenient access to a wide array of health insurance products through insurance brokerage services under Insurance-related Services, its online insurance marketplace. As of June 30, 2025, a total of 294 insurance products from 58 insurer partners had been offered on Insurance-related Services.
--
The Group have developed Aicare, its proprietary AI technology stack. As of June 30, 2025, it had registered 58 invention patents and 39 copyrighted software in relation to technology capabilities.
--
The Group’s customers primarily include insurer partners, pharmaceutical companies and individual customers for its integrated health service packages.
BASIC INFORMATION
| Market | Hong Kong (Main Board) |
| Business Nature | Software & Services |
| Major Business Area | China |
| Board Lot | 200 |
GLOBAL OFFERING
| No. of Offer Shares | 26.54M shares |
| No. of International Offer Shares | 23.89M shares |
| No. of HK Offer Shares | 2.65M shares |
| Offer Price | $22.68 |
| Stock Code | 2661 |
| Sponsor(s) | China International Capital Corporation Hong Kong Securities Limited, China Merchants Securities (HK) Co., Limited |
| Underwriter(s) | China International Capital Corporation Hong Kong Securities Limited, China Merchants Securities (HK) Co., Limited, Futu Securities International (Hong Kong) Limited, SPDB International Capital Limited |
TIME TABLE
| Application Period | Dec 15 (Mon) - noon, Dec 18 (Thu) |
| Price Determination Date | -- |
| Result Announcement Date | On or before Dec 22 (Mon) |
| Result Announcement Date | On or before Dec 22 (Mon) |
| Result Announcement Date | On or before Dec 23 (Tue) |
| Dealings in Shares commence on | Dec 23, 2025. (Tue) |
Reallocation of Shares Offered
Sales Statistics (HKD)
| Offer Price | $22.68 |
| Capitalization | 4.68B |
| NAV / share ($) | -- |
Use Of Proceeds
| Assuming the offer price being at HKD 22.68, the net proceeds raised would be HKD 513.40M, of which |
| 40% : Increase brand visibility, enhance user engagement and strengthen cooperation with business partners |
| 20% : Medical studies and real-world research |
| 20% : Enhance technology capabilities in AI and big data for wider application in products and services |
| 10% : Expand into more regional and overseas market |
| 10% : Working capital |
Related Document
| Prospectus |  Chinese Version | English Version |
| Remark： | The above information is referenced from the prospectus. |
| All data is calculated from the non- exercise rights(if applicable). |
Name︰
--
--
--
Subscription --
Result Announcement --
Listing --Offer Price︰--
| Currency | : |
| Listing Price | : |
| Board Lot | : |
| Admission Fee* |
: |
| Subscribing Lot | : |
| Subscribing Fee | : |
| Subscribing Amount | : |
*Admission fees include brokerage of 1%, SFC transaction levy of 0.0027%, Stock Exchange trading fee of 0.005% and FRC transaction levy of 0.00015% (i.e. 1.0077% in total).